Protozoa Antigen Ingredients TRIZ Cases
- Oocyst Processing Chamber for In Situ Sporocyst Release
Mechanical disruption releases viable sporocysts from oocysts before dosing, improving hatchling vaccination without cryopreservation.
- E140 Malaria Antigen Vaccine for Broad Immune Protection
A single E140 malaria antigen triggers both cellular and humoral immunity, broadening protection while avoiding multi-antigen vaccine complexity.
- PEGylated Retinoic Acid Liposomes for Intranasal Vaccine Delivery
PEGylated liposomes encapsulate retinoic acid to boost intranasal vaccine uptake while reducing mucosal irritation and improving protection.
- Acetylated Traspain Vaccine Composition for Chagas Immunotherapy
Chemically modified Traspain improves solubility and antigenicity, enabling stronger Th1/CD8+ responses and lower-dose Chagas drug therapy.
- Leishmania Exosomes for Targeted Cancer Drug Delivery
Parasite-derived exosomes target cancer cells, carry drugs with higher bioavailability, and reduce harm to healthy tissue.
- Aziridine-Treated gp40 Vaccine for Lower-Dose Cryptosporidiosis Protection
Aziridine incubation raises gp40 immunogenicity, enabling a 10–20-fold lower dose with fewer local reactions.
- Chimeric Protein Adjuvant for Reproducible Immune Response
Genetically fused chimeric protein adjuvant enhances immunogenic potential of antigens.
- Fusion Polypeptide Vaccine Antigens for Leishmaniasis Protection
Fusion polypeptides combine multiple Leishmania antigens to stimulate protective immunity, addressing inadequate protection from single-antigen vaccines.